Genprex Inc (NASDAQ:GNPX) shares, rose in value on Wednesday, April 16, with the stock price down by -1.73% to the previous day’s close as strong demand from buyers drove the stock to $0.26.
Actively observing the price movement in the last trading, the stock closed the session at $0.26, falling within a range of $0.235 and $0.2613. The value of beta (5-year monthly) was -0.386. Referring to stock’s 52-week performance, its high was $4.09, and the low was $0.22. On the whole, GNPX has fluctuated by -24.85% over the past month.
With the market capitalization of Genprex Inc currently standing at about $6.17 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-30.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GNPX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of GNPX currently trading nearly -17.17% and -29.35% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.62, while the 7-day volatility ratio is showing 12.05% which for the 30-day chart, stands at 19.86%. Furthermore, Genprex Inc (GNPX)’s beta value is -0.38, and its average true range (ATR) is 0.05.
A comparison of Genprex Inc (GNPX) with its peers suggests the former has fared considerably weaker in the market. GNPX showed an intraday change of -1.73% in last session, and over the past year, it shrunk by -89.13%%.
Data on historical trading for Genprex Inc (NASDAQ:GNPX) indicates that the trading volumes over the past 10 days have averaged 8.28 and over the past 3 months, they’ve averaged 4.01 million. According to company’s latest data on outstanding shares, there are 24.15 million shares outstanding.
Nearly 2.73% of Genprex Inc’s shares belong to company insiders and institutional investors own 1.21% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.28 million shares as on 2025-03-31, resulting in a short ratio of 0.07. According to the data, the short interest in Genprex Inc (GNPX) stood at 115.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.63 million. The stock has fallen by -70.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GNPX stock heading into the next quarter.
